🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Contineum Therapeutics, Inc. Class A Common Stock
Market Cap: Medium
Employees: Lowest
PIPE-791
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need.
Symbol: CTNM
Recent Price: $14.47
Industry: Biotechnology
CEO: Mr. Carmine N. Stengone MBA, MS
Sector: Healthcare
Employees: 31
Address: 10578 Science Center Drive, San Diego, CA 92121
Phone: (858) 333-5280
Leadership
- Carmine Stengone, President and Chief Executive Officer
- Austin Chen, PhD, Senior Vice President, Head of Research
- Beverly Dixon, Senior Director, Quality Assurance
- Kristina Haeckl, Sr. Vice President, Regulatory Affairs
- Daniel Lorrain, PhD, Chief Scientific Officer
- John Healy, General Counsel & Corporate Secretary
- Jon Seiders, PhD, Vice President, CMC
- Jules Lee, Senior Director, Clinical Operations
- Julie Iwashita, Vice President, Clinical Operations
- Karin Stebbins, Vice President, Toxicology
- Michael Mayberry, Vice President, Finance
- Mike Poon, PhD, Vice President, Biology
- Peter Slover, Chief Financial Officer
- Stephen Huhn, MD, Chief Medical Officer & Senior Vice President, Clinical Development
- Tara Vargas, Senior Director, Project Management
- Thomas O. Schrader, PhD, Senior Director, Chemistry
- Varsha Dourado, Vice President, Business Development
Last updated: 2024-12-31